| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9153703 | American Heart Journal | 2005 | 7 Pages |
Abstract
Early administration of abciximab improves epicardial patency (TIMI flow) before PCI and results in better myocardial tissue perfusion (ST-resolution) after the procedure. The promising effects on clinical outcomes need to be tested in larger studies.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jochen MD, Marcus FRCP, Marko MD, Mariann MD, Hans-Richard MD, Lars MD, PhD, Henrique Mesquita MD, Kurt MD, Fiona BSc, Joachim MD, Leif MD, Duolao PhD, Simona MD, Gilles MD, PhD,